# A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)

> **NCT00705289** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 728 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT00705289
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705289, "A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00705289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*